Fundraising FoxAlly Bridge Group — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Syrossyros.comDec 2020
Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.
Nancy Simonian(CEO)
Co-investorsAisling CapitalARCH Venture PartnersQuan CapitalAlexandriaBain CapitalBain Capital Life Sciences+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.